Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)

NCT00796770 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: Dendritic Cell Vaccine

Sponsor

Baylor Research Institute

Collaborators

[object Object]